Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

ICE regimen

View Patient Information
A regimen consisting of carboplatin, etoposide and ifosfamide that can be used in the treatment of non-Hodgkin and Hodgkin lymphomas, including diffuse large B-cell lymphoma and T-cell lymphoma, mycosis fungoides/Sezary syndrome, and gestational trophoblastic neoplasia. Paclitaxel/carboplatin/oral etoposide regimen can be used for the treatment of occult primary adenocarcinoma.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:carboplatin/etoposide/ifosfamide
ifosfamide-carboplatin-etoposide regimen
ifosfamide/carboplatin/etoposide
ifosfamide/carboplatin/etoposide
iosfamide-carboplatin-etoposide regimen
Abbreviation:CBDCA/IFF/VP-16
Acronym:ICE
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search